1. Home
  2. TMCI vs ONCY Comparison

TMCI vs ONCY Comparison

Compare TMCI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$3.73

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.81

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMCI
ONCY
Founded
2014
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
98.7M
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
TMCI
ONCY
Price
$3.73
$0.81
Analyst Decision
Hold
Strong Buy
Analyst Count
6
4
Target Price
$4.77
$7.33
AVG Volume (30 Days)
622.2K
1.3M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$212,690,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.18
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
1.59
N/A
52 Week Low
$1.17
$0.43
52 Week High
$7.78
$1.51

Technical Indicators

Market Signals
Indicator
TMCI
ONCY
Relative Strength Index (RSI) 74.48 41.41
Support Level $2.46 N/A
Resistance Level $3.80 $1.14
Average True Range (ATR) 0.24 0.08
MACD 0.03 -0.00
Stochastic Oscillator 93.44 9.76

Price Performance

Historical Comparison
TMCI
ONCY

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: